AU4158799A - Probes used for genetic filing - Google Patents

Probes used for genetic filing

Info

Publication number
AU4158799A
AU4158799A AU41587/99A AU4158799A AU4158799A AU 4158799 A AU4158799 A AU 4158799A AU 41587/99 A AU41587/99 A AU 41587/99A AU 4158799 A AU4158799 A AU 4158799A AU 4158799 A AU4158799 A AU 4158799A
Authority
AU
Australia
Prior art keywords
filing
genetic
probes used
probes
genetic filing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41587/99A
Inventor
Gareth Wyn Roberts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENOSTIC PHARMA Ltd
Original Assignee
GENOSTIC PHARMA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9812099.1A external-priority patent/GB9812099D0/en
Priority claimed from GBGB9813291.3A external-priority patent/GB9813291D0/en
Priority claimed from GBGB9813611.2A external-priority patent/GB9813611D0/en
Priority claimed from GBGB9813835.7A external-priority patent/GB9813835D0/en
Priority claimed from GBGB9814110.4A external-priority patent/GB9814110D0/en
Priority claimed from GBGB9814580.8A external-priority patent/GB9814580D0/en
Priority claimed from GBGB9815438.8A external-priority patent/GB9815438D0/en
Priority claimed from GBGB9815576.5A external-priority patent/GB9815576D0/en
Priority claimed from GBGB9815574.0A external-priority patent/GB9815574D0/en
Priority claimed from GBGB9816085.6A external-priority patent/GB9816085D0/en
Priority claimed from GBGB9816086.4A external-priority patent/GB9816086D0/en
Priority claimed from GBGB9816921.2A external-priority patent/GB9816921D0/en
Priority claimed from GBGB9817097.0A external-priority patent/GB9817097D0/en
Priority claimed from GBGB9817200.0A external-priority patent/GB9817200D0/en
Priority claimed from GBGB9817632.4A external-priority patent/GB9817632D0/en
Priority claimed from GBGB9817943.5A external-priority patent/GB9817943D0/en
Application filed by GENOSTIC PHARMA Ltd filed Critical GENOSTIC PHARMA Ltd
Publication of AU4158799A publication Critical patent/AU4158799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU41587/99A 1998-06-06 1999-06-04 Probes used for genetic filing Abandoned AU4158799A (en)

Applications Claiming Priority (33)

Application Number Priority Date Filing Date Title
GB9812099 1998-06-06
GBGB9812099.1A GB9812099D0 (en) 1998-06-06 1998-06-06 Behavioural disturbances
GB9813291 1998-06-20
GBGB9813291.3A GB9813291D0 (en) 1998-06-20 1998-06-20 Sexual dysfunction
GB9813611 1998-06-24
GBGB9813611.2A GB9813611D0 (en) 1998-06-24 1998-06-24 Headache
GBGB9813835.7A GB9813835D0 (en) 1998-06-27 1998-06-27 Brain injury
GB9813835 1998-06-27
GB9814110 1998-07-01
GBGB9814110.4A GB9814110D0 (en) 1998-07-01 1998-07-01 Dementia
GBGB9814580.8A GB9814580D0 (en) 1998-07-07 1998-07-07 Oncology
GB9814580 1998-07-07
GBGB9815438.8A GB9815438D0 (en) 1998-07-16 1998-07-16 Cardiovascular disorders
GB9815438 1998-07-16
GBGB9815576.5A GB9815576D0 (en) 1998-07-18 1998-07-18 Central nervous system (neurological, neuropsychiatric, phychiatric, Psychological and social) dysfunction, disease and damage
GBGB9815574.0A GB9815574D0 (en) 1998-07-18 1998-07-18 Metabolic and endocrine functions, disorders and disease
GB9815574 1998-07-18
GB9815576 1998-07-18
GB9816086 1998-07-24
GB9816085 1998-07-24
GBGB9816085.6A GB9816085D0 (en) 1998-07-24 1998-07-24 Injury,inflammation,immunity and infection
GBGB9816086.4A GB9816086D0 (en) 1998-07-24 1998-07-24 Psychoses and personality
GB9816921 1998-08-05
GBGB9816921.2A GB9816921D0 (en) 1998-08-05 1998-08-05 Respiratory system
GB9817097 1998-08-07
GBGB9817097.0A GB9817097D0 (en) 1998-08-07 1998-08-07 Gastrointestinal function
GB9817200 1998-08-08
GBGB9817200.0A GB9817200D0 (en) 1998-08-08 1998-08-08 Skin,muscle,connective tissue and bone
GBGB9817632.4A GB9817632D0 (en) 1998-08-14 1998-08-14 Development
GB9817632 1998-08-14
GB9817943 1998-08-19
GBGB9817943.5A GB9817943D0 (en) 1998-08-19 1998-08-19 Genostics and drugs
PCT/GB1999/001780 WO1999064627A2 (en) 1998-06-06 1999-06-04 Probes used for genetic profiling

Publications (1)

Publication Number Publication Date
AU4158799A true AU4158799A (en) 1999-12-30

Family

ID=27585626

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41587/99A Abandoned AU4158799A (en) 1998-06-06 1999-06-04 Probes used for genetic filing

Country Status (2)

Country Link
AU (1) AU4158799A (en)
WO (1) WO1999064627A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69423436T2 (en) 1993-06-25 2000-09-07 Smithkline Beecham Plc PHOSPHOLIPASE A2 TIED TO LIPOPROTEIN, INHIBITORS THEREOF AND THEIR USE FOR DIAGNOSIS AND THERAPY
CN1291229A (en) 1998-02-19 2001-04-11 东弗吉尼亚医学院 Recombinant active human zona pellucida protein 3 (h2P3)
US7037663B2 (en) 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
US7058517B1 (en) 1999-06-25 2006-06-06 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
US6931326B1 (en) 2000-06-26 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
DE10037769A1 (en) * 2000-08-03 2002-02-21 Epigenomics Gmbh Diagnosis of diseases associated with CD24
DE10054972A1 (en) * 2000-11-06 2002-06-06 Epigenomics Ag Diagnosis of diseases associated with humus
DE10054974A1 (en) * 2000-11-06 2002-06-06 Epigenomics Ag Diagnosis of diseases associated with Cdk4
DE10061338A1 (en) * 2000-12-06 2002-06-20 Epigenomics Ag Diagnosis of diseases associated with angiogenesis
CA2456821A1 (en) 2001-08-02 2003-02-13 Trinity Biomedical Technology Corporation Human zona pellucida proteins and methods of their use in diagnosing male infertility
US20040231909A1 (en) 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
CA3048093A1 (en) * 2003-11-26 2005-06-23 Celera Corporation Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof
KR20220012993A (en) * 2004-07-23 2022-02-04 퍼시픽 에지 리미티드 Urine markers for detection of bladder cancer
JP5297202B2 (en) * 2006-01-11 2013-09-25 ジェノミック ヘルス， インコーポレイテッド Gene expression markers for prognosis of colorectal cancer
US7943328B1 (en) 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US7888019B2 (en) 2006-03-31 2011-02-15 Genomic Health, Inc. Genes involved estrogen metabolism
US20080085524A1 (en) 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
WO2008055341A1 (en) * 2006-11-09 2008-05-15 Centre For Addiction And Mental Health Slc1a1 antipsychotic drug response markers
WO2010127322A1 (en) 2009-05-01 2010-11-04 Genomic Health Inc. Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy
AU2011282892B2 (en) 2010-07-27 2015-07-16 Mdxhealth Sa Method for using gene expression to determine prognosis of prostate cancer
MX366164B (en) 2012-01-31 2019-07-01 Genomic Health Inc Gene expression profile algorithm and test for determining prognosis of prostate cancer.
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
GB201504502D0 (en) * 2015-03-17 2015-04-29 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
CN106290668B (en) * 2016-11-01 2018-08-17 中国科学院南京土壤研究所 The extraction purification assay method of acyl homoserine lactones and its application in a kind of soil
US20210236654A1 (en) * 2018-04-27 2021-08-05 Decibel Therapeutics, Inc. Myosin 15 promoters and uses thereof
KR20230051519A (en) 2020-08-15 2023-04-18 리제너론 파마슈티칼스 인코포레이티드 Treatment of obesity in a subject with a variant nucleic acid molecule encoding the calcitonin receptor (CALCR)
CN114634981B (en) * 2020-12-16 2024-01-26 广州达健生物科技有限公司 Liver cancer gene methylation detection primer probe combination, kit and application thereof

Also Published As

Publication number Publication date
WO1999064627A8 (en) 2000-06-29
WO1999064627A2 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
AU4158799A (en) Probes used for genetic filing
AU2084299A (en) Information routing
AU5547900A (en) Sample holder
AU8329798A (en) Primers for obtaining highly informative dna markers
AU3568799A (en) Booklet
AU3954699A (en) Writing instrument
AU3208699A (en) P40 protein acts as an oncogene
AU3628199A (en) Writing instrument
AU3266999A (en) Nanotribological probe microscope
AU3178200A (en) Genetic analysis
AU6417799A (en) Matrix-remodeling genes
AUPP425898A0 (en) An improved grating writing system
AU5044299A (en) Multipurpose support
AU3981799A (en) Method for identifying genes
AU1323900A (en) Handchime instrument
AU3100799A (en) Methods for identifying anti-cancer agents
AU3834199A (en) Holder
AU2227799A (en) Adapter
EP1126980A4 (en) Booklet
AU2464400A (en) Probe card
AU6433499A (en) Tnfr related gene 12
AUPP438598A0 (en) NPY-Y7 receptor gene
AU4513599A (en) Nucleotide sequence
AU5304499A (en) Hybridization probe
AU3444300A (en) Genetic analysis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase